• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » FDA takes another look at ‘spinal spheres’ and stair-climbing wheelchairs

FDA takes another look at ‘spinal spheres’ and stair-climbing wheelchairs

November 11, 2013 By Arezu Sarvestani

FDA takes another look at 'spinal spheres'

FDA regulators plan to meet next month to review a handful of medical devices and possibly recommend reclassification for spinal fusion ‘spheres’ and both stair-climbing and mechanical wheelchairs.

The agency noted in the Federal Register that its Orthopaedic & Rehabilitation Devices Panel will meet December 12 to review the technologies based on new reviews of their safety and effectiveness.

The agency plans to take another look at spinal sphere devices, which are inserted in the spine "to help provide stabilization and to help promote inter-vertebral body fusion" during fusion procedures. The technology is considered a "pre-amendment" device because they’ve been on the market since 1976, and are treated as unclassified devices reviewed under the less-stringent 510(k) program, according to the notice.

The advisory panel also plans to review stair-climbing wheelchairs, as requested last year by DEKA Research & Development Corp. DEKA was founded by New England tech celebrity Dean Kamen, who perhaps most commonly known for having invented the Segway but has also invented revolutionary products in robotic prosthetics and water purification systems.

DEKA developed the iBOT system, an FDA-approved high-tech wheelchair that can navigate difficult terrain, climb up or down stairs and rise to "stand" at eye level. DEKA requested in November 2012 that the FDA reconsider classifying the devices from the highest-risk Class III category to a Class II, where they will fall under the 510(k) review pathway. Earlier this year the FDA issued a proposed order to do just that, and the order is now awaiting finalization.

The panel will also discuss possible reclassification of less advanced mechanical wheelchairs to a higher-risk category, from Class I to Class II, the FDA said.

"The committee will discuss whether general and/or special controls are appropriate to demonstrate a reasonable assurance of safety and effectiveness of mechanical wheelchairs and whether, if reclassified to Class II, these devices should be exempt from premarket notification (510(k)) requirements," according to the FDA notice.

Filed Under: Food & Drug Administration (FDA), News Well, Orthopedics, Regulatory/Compliance, Spine

More recent news

  • Data backs Medtronic MiniMed 780G for type 2, children as company seeks expanded indications
  • Endogenex data supports type 2 diabetes procedure
  • Ambu wins FDA clearance for first single-use cysto-nephroscope
  • Tandem Diabetes Care pairs t:slim X2 pump with Abbott FreeStyle Libre 3 Plus in U.S.
  • Ypsomed, CamDiab to integrate Abbott dual glucose-ketone sensor into automated insulin delivery system

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy